Study protocol: An open-label individually randomised controlled trial to assess the efficacy of artemether-lumefantrine prophylaxis for malaria among forest goers in Cambodia
Introduction In the Greater Mekong Subregion, adults are at highest risk for malaria. The most relevant disease vectors bite during daytime and outdoors which makes forest work a high-risk activity for malaria. The absence of effective vector control strategies and limited periods of exposure during...
Saved in:
Main Authors: | Richard James Maude, Rupam Tripura, Mom Ean, Meas Sokha, Thomas Julian Peto, James John Callery, Mallika Imwong, Ranitha Vongpromek, Joel Tarning, Mavuto Mukaka, Naomi Waithira, Oung Soviet, Lorenz Von Seidlein, Siv Sovannaroth |
---|---|
Other Authors: | Faculty of Tropical Medicine, Mahidol University |
Format: | Article |
Published: |
2022
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/78038 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Acceptability and feasibility of malaria prophylaxis for forest goers: findings from a qualitative study in Cambodia
by: Monnaphat Jongdeepaisal, et al.
Published: (2022) -
Triple therapy with artemether–lumefantrine plus amodiaquine versus artemether–lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial
by: Thomas J. Peto, et al.
Published: (2022) -
Triple therapy with artemether–lumefantrine plus amodiaquine versus artemether–lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial
by: Peto T.J.
Published: (2023) -
How can interventions that target forest-goers be tailored to accelerate malaria elimination in the Greater Mekong Subregion? A systematic review of the qualitative literature
by: Stephanie D. Nofal, et al.
Published: (2020) -
The clinical efficacy of artemether/lumefantrine (Coartem)
by: Makanga, Michael, et al.
Published: (2012)